Angel Garcia de Lucas

angel.garciadelucas@utu.fi

ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience (2023)
- Biomolecules
Lucas de García Ángel, Lamminmäki Urpo, López-Picón R. Francisco
MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management (2018)
- Contrast Media and Molecular Imaging
Morcillo MÁ, García de Lucas Á, Oteo M, Romero E, Magro N, Ibáñez M, Martínez A, Garaulet G, Arroyo AG, López-Casas PP, Hidalgo M, Mulero F, Martínez-Torrecuadrada J.
Preparation of ⁶⁸Ga-labelled DOTA-peptides using a manual labelling approach for small-animal PET imaging (2016) Romero E, Martínez A, Oteo M, García A, Morcillo MA
Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas (2016)
- PLoS ONE
de Lucas AG, Schuhmacher AJ, Oteo M, Romero E, Cámara JA, de Martino A, Arroyo AG, Morcillo MÁ, Squatrito M, Martinez-Torrecuadrada JL, Mulero F.
GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085 (2015)
- Biochemical Pharmacology
de Lucas AG, Ahring PK, Larsen JS, Rivera-Arconada I, Lopez-Garcia JA, Mirza NR, Munro G.
Alzheimer's disease amyloid peptides interact with DNA, as proved by surface plasmon resonance (2012)
- Current Alzheimer Research
Barrantes A, Camero S, Garcia-Lucas A, Navarro PJ, Benitez MJ, Jiménez JS.